Search Browse Earnings

FibroBiologics, Inc. — SlamSEC

FibroBiologics, Inc.

Nasdaq:FBLG

Pharmaceutical Preparations·HOUSTON, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$13.6M

FY 2025

Net Income

-$11.2M

FY 2025

EPS (Diluted)

-$0.34

FY 2025

Stock Price

$0.40

-4.7%

2026-03-09

52W Range

$0.22 – $1.53

P/E Ratio

-1.2x

Market Cap

$27.0M

Cash

$14.0M

FY 2025

Total Debt

$300,000

FY 2024

Net Cash

$13.7M

FY 2024

Enterprise Value

$13.4M

Debt / EBITDA

1.0x

FY 2025

EV / EBITDA

-1.0x

Employees

—

CEO

O'Heeron Pete

CFO

Davis Jason